PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 25916750-6 2015 In patients with cHL receiving doxorubicin, bleomycin, vinblastine and dacarbazine, those expressing IGF-1R showed a trend towards better OS and event-free survival than IGF-1R-negative patients (P = 0.129 and P = 0.115 respectively), but statistical significance was not reached. Bleomycin 44-53 insulin like growth factor 1 receptor Homo sapiens 101-107 32795835-6 2020 Blockage of IGF-1R decreases lung tissue damage and increases survival in bleomycin-induced as well as H1N1 influenza-related lung injury in animal models. Bleomycin 74-83 insulin like growth factor 1 receptor Homo sapiens 12-18